← Back to Patent Explorer
US4774322A Expired / Lapsed US ⏱️ 0.0 years remaining

Polypeptide cartilage-inducing factors found in bone

Assignee: Celtrix Pharmaceuticals Inc
•
Filing: 1987-12-10
•
Granted: 1988-09-27
•
Expires: 2007-12-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Two proteins that are found in bone and that have in vivo chondrogenic/osteogenic activity in combination with a co-factor are described. Both proteins also were active in combination with EGF in the in vitro TGF-β assay. Each has a molecular weight of approximately 26,000 daltons by SDS-PAGE. Each is reduced to a single polypeptide indicating that the proteins are probably homodimers. One has an N-terminal sequence identical to that of human placenta-derived TGF-β whereas the other has an N-terminal sequence that is different from that of TGF-β derived from human placenta. The two proteins may be purified to homogeneity using RP-HPLC or acetic acid-urea gel electrophoresis.

Inventors

  • 👤 Saeid Seyedin
  • 👤 Thomas Thomas
  • 👤 Hanne Bentz
  • 👤 Larry Ellingsworth
  • 👤 Rosa Armstrong

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 05:43
CPC Classifications
B; B64; B64C; B64C11/00; A; A61; A61K; A61K35/00; A61K35/12; A61K35/32; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; B65; B65B; B65B35/00; B65B35/30; B65B35/50; B65H; B65H31/00; B65H31/30; B65H31/3009; C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/495; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/84; Y10S530/841; Y10S623/00; Y10S623/924; Y10S930/00; Y10S930/01; Y10S930/12

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 66 words
A polypeptide that: (a) is found in mammalian bone; (b) is a co-factor for inducing cartilage formation; (c) is active in the TGF-β assay; (d) is a dimer having a molecular weight of approximately 26,000 daltons as determined by SDS-PAGE, whose chains each have the following N-terminal sequence: Ala-Leu-Asp-Ala-Ala-Tyr-Cys-Phe-Arg-Asn-Val-Gl[u]n-Asp-Asn-Cys-Cys-Leu-Arg-Pro-Leu-Tyr-Ile-Asp-Phe-Lys-Arg-Asp-Leu-Gly-Trp-; and (e) is substantially pure, and polypeptides that are substantially pure and substantially equivalent to said polypeptide.
Claim 2
Dependent Claim 66 words
A polypeptide that: (a) is found in mammalian bone; (b) is a co-factor for inducing cartilage formation; (c) is active in the TGF-β assay; (d) is a dimer having a molecular weight of approximately 26,000 daltons as determined by SDS-PAGE, whose chains each have the following N-terminal sequence: Ala-Leu-Asp-Ala-Ala-Tyr-Cys-Phe-Arg-Asn-Val-Gl[u]n-Asp-Asn-Cys-Cys-Leu-Arg-Pro-Leu-Tyr-Ile-Asp-Phe-Lys-Arg-Asp-Leu-Gly-Trp-; and (e) is substantially pure, and polypeptides that are substantially pure and substantially equivalent to said polypeptide.

References Cited (Backward Citations)

US4294753A Cited
WO1984001106A1 Cited
US4434094A Cited
EP0128849A1 Cited
US4563350A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-27 1992-03-28 1992-09-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-27 1996-03-28 1996-09-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-27 2000-03-28 2000-09-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag